International Journal of Drug Policy
Volume 16, Issue 3 , Pages 150-160 , June 2005

Police drug crackdowns and hospitalisation rates for illicit-injection-related infections in New York City

  • Hannah L.F. Cooper

      Affiliations

    • Medical Health and Research Association of NYC, Inc./National Development and Research Institutes, Inc., 71 West 23rd Street, 8th Floor, New York, NY 10010, USA
    • Department of SocioMedicine Sciences, Columbia Mailman School of Public Health, 722 West 168th Street, 9th Floor, New York, 10032
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 845 4641; fax: +1 917 438 0894.
    • ,
  • David Wypij

      Affiliations

    • Clinical Research Program, Harvard Medical School, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA
    • Tel.: +1 617 355 2641; fax: +1 617 355 2312.
    • ,
  • Nancy Krieger

      Affiliations

    • Department of Society, Human Development, and Health, Harvard School of Public Health, 677 Huntington Avenue, 7th Floor, Boston, MA 02115, USA
    • Tel.: +1 617 432 1571; fax: +1 617 432 3123.

Received 14 June 2004 ,Accepted 18 March 2005.

References 

  1. Aitken C, Moore D, Higgs D, Kelsall J, Kerger M. The impact of a police crackdown on a street drug scene: Evidence from the street. The International Journal of Drug Policy. 2002;13:189–198
  2. Best D, Strang J, Beswick T, Gossop M. Assessment of a concentrated high-profile police operation: No discernable impact on drug availability, price, or purity. British Journal of Criminology. 2001;41:738–745
  3. Bluthenthal R, Kral A, Erringer E, Edlin B. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. Journal of Drug Issues. 1999;29(1):1–16
  4. Bluthenthal R, Kral A, Lorvick J, Watters J. Impact of law enforcement on syringe exchange programs: A closer look at Oakland and San Francisco. Medical Anthropology. 1997;18:61–83
  5. Bluthenthal R, Lorvick J, Kral A, Erringer E, Kahn J. Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. International Journal of Drug Policy. 1999;10:25–38
  6. Bluthenthal, R., & Watters, J. (1995). Multi-method research: From targeted sampling to HIV risk behaviors. In Qualitative methods in the prevention of drug abuse and HIV research (Vol. 157, pp. 212–230). Rockville, MD: National Institute on Drug Abuse.
  7. Bourgois P, Lettiere M, Quesada J. Social misery and the sanctions of substance abuse: Confronting HIV risk among homeless heroin addicts in San Francisco. Social Problems. 1997;44(2):155–173
  8. Boyum, D., & Kleiman, M. (1994). Drug abuse control policy from a crime-control perspective (Vol. R94–16). Cambridge, MA: John F. Kennedy School of Government, Harvard University (Faculty Research Working Paper Series).
  9. Chen K, Kandel D. The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health. 1995;85(1):41–47
  10. Ciccarone D, Bamberger J, Kral A, Edlin B, Hobart C, Moon A, et al. Soft tissue infections among injection drug users—San Francisco, California, 1996–2000. Morbidity and Mortality Weekly. 2001;50(19):381–383
  11. Cooper H, Moore L, Gruskin S, Krieger N. Characterizing perceived police-related violence: Implications for public health. The American Journal of Public Health. 2004;94(7):1109–1118
  12. Cooper, H., Moore, L., Gruskin, S., & Krieger, N. (in press). The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: A qualitative study. Social Science and Medicine.
  13. Curtis R. Crack, cocaine, and heroin: Drug eras in Williamsburg, Brooklyn, 1960–2000. Addiction Research and Theory. 2003;11(1):47–63
  14. Des Jarlais D, Friedman S, Perlis T, Chapman T, Sotheran J, Paone D, et al. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999;20:67–72
  15. Des Jarlais D, Marmor M, Friedmann P, Titus S, Aviles E, Deren S, et al. HIV incidence among injection drug users in New York City, 1992–1997: Evidence for a declining epidemic. American Journal of Public Health. 2000;90(3):352–359
  16. Des Jarlais D, Perlis T, Friedman S, Chapman T, Kwok J, Rockwell R, et al. Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990–1997. American Journal of Public Health. 2000;90(7):1112–1116
  17. DeWitt D, Paauw D. Endocarditis infection in injection drug users. American Family Physician. 1996;53(6):2045–2049
  18. Diggle P, Liang K, Zegler S. The analysis of longitudinal data. New York: Oxford University Press; 1994;
  19. Farley J, Mitty J, Mally M, Buzynski J, Tashima K, Rich J, et al. Comprehensive medical care among HIV-positive incarcerated women: The Rhode Island experience. Journal of Women's Health Care and Gender-Based Medicine. 2000;9(1):51–56
  20. Federal Bureau of Investigation. (2003). Crime in the United States, 2003; from http://www.ojp.usdoj.gov/bjs/dcf/tables/salespos.htm.
  21. Fordyce E, Shum R, Singh T, Forlenza S. Economic and geographic diversity in AIDS incidence among HIV exposure groups in New York City: 1983–1995. AIDS and Public Policy Journal. 1998;13(3):103–114
  22. Friedman S, Chapman T, Perlis T, Rockwell R, Paone D, Sotheran J, et al. Similarities and differences by race/ethnicity in changes in HIV seroprevalence and related behaviors among drug injectors in New York City, 1991–1996. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999;22(1):83–91
  23. Friedman SR, Tempalski B, Cooper H, Perlis T, Keem M, Friedman R, et al. Estimating numbers of IDUs in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for IDUs. The Journal of Urban Health. 2004;81(3):377–400
  24. Giuliani, R. (1997). Removing drugs from our neighbourhoods and schools. Retrieved October 20, 1999; from http://www.ci.nyc.us/hymllom/html/nodrugs.html.
  25. Greene L. Policing places with drug problems. Thousand Oaks, CA: Sage Publications; 1996;
  26. Grund J-P, Heckathorn D, Anthony D. In Eastern Connecticut, IDUs purchase syringes from pharmacies but don’t carry syringes. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1995;10:105
  27. Haverkos H, Turner F, Moolchan E, Cadet J-L. Relative rates of AIDS among racial/ethnic groups by exposure category. Journal of the National Medical Association. 1999;91(1):17–24
  28. Herb, F., Watters, J., Case, P., & Petitti, D. (1989). Endocarditis, subcutaneous abscesses, and other bacterial infections in intravenous drug users and their association with skin-cleaning at drug injection sites. Paper presented at the 5th International Conference on AIDS, June 1989, Montreal, Canada, Abstract No. ThD04.
  29. Holmberg, S. (1993). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas: Supplementary material. Unpublished manuscript.
  30. Joshi N, Caputo G, Weitecamp M, Karchner A. Infections in patients with diabetes mellitus. New England Journal of Medicine. 1999;341(25):1906–1912
  31. Kelling, G., & Moore, M. (1985). Observations on the police industry (Program on Criminal Justice Policy and Management No. 85-05-03). Cambridge, MA: John F. Kennedy School of Government, Harvard University (Working Paper, Program on Criminal Justice Policy and Management, 85-05-03).
  32. Koester S. Copping, running and paraphernalia laws: Contextual variables and needle risk behavior among injection drug users in Denver. Human Organization. 1994;53(3):287–295
  33. Krieger N, Waterman P, Lemieux K, Zierler S, Hogan J. On the wrong side of the tracts? Evaluating the accuracy of geocoding in public health research. American Journal of Public Health. 2001;91:1114–1116
  34. Maher L, Dixon D. Policing and public health: Law enforcement and harm minimization in a street-level drug market. British Journal of Criminology. 1999;39(4):488–512
  35. Marzuk P, Tardiff K, Leon A, Hirsch C, Stajic M, Portrera L, et al. Poverty and fatal overdoses of cocaine and opiates in New YorkCity: An ecological study. American Journal of Drug and Alcohol Abuse. 1997;23(2):221–228
  36. Moore, M. (1990). An analytic view of drug control policies (Program in Criminal Justice Policy and Management No. 90-01-9). Cambridge, MA: John F. Kennedy School of Government, Harvard University (Working Paper, Program in Criminal Justice Policy and Management, 90-01-9).
  37. Murasko D, Bernstein E. Immunology of aging. In:  Hazzard W,  Bless J,  Ettinger W,  Hattes J,  Ouslander J editor. Principles of geriatric medicine and gerontology. 4th ed.. New York: McGraw-Hill; 1999;p. 97–116
  38. Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft tissue abscess among injection drug users: A case–control study. Clinical Infectious Diseases. 2001;33(1):35–40
  39. National Institute of Justice. (1999). 1998 adult program findings. Retrieved August 2002, 2002; from http://www.adam.nij.net/adultfind.pdf.
  40. New York Division of Criminal Justice Services . New York City arrest file codebook. Albany, NY: Bureau of Statistical Services, State of New York Division of Criminal Justice Services; 2000;
  41. Raveis V, Kandel D. Changes in drug behavior from the middle to late twenties: Initiation, persistence, and cessation of use. American Journal of Public Health. 1987;77(5):607–611
  42. Rhodes T. The “risk environment”: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy. 2002;13:85–94
  43. Rich J, Strong L, Towe C, McKenzie M. Obstacles to needle exchange participation in Rhode Island. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999;21(5):396–400
  44. Schrager L, Friedlan G, Feinder C, Kahl P. Demographic characteristics, drug use and sexual behavior of iv drug users with AIDS In New York. Public Health Reports. 1991;106(1):78–84
  45. Shutz C, Rapiti E, Vlahov D, Anthony J. Suspected determinants of enrollment into detoxification and methadone treatment among injection drug users. Drug and Alcohol Dependence. 1994;36:129–138
  46. Spijkerman I, van Ameijden E, Mientjes G, Coutinho R, van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. Journal of Clinical Epidemiology. 1997;49(10):1149–1154
  47. Stone M, Stone D, MacGregor H. Anatomical distribution of soft tissue infections in intravenous drug misusers attending an accident and emergency department. British Journal of Addiction. 1990;85:1495–1496
  48. Straumann E, Stulz P, Jenzer H. Tricuspid valve endocarditis in the drug addict: A reconstructive approach (‘vegetectomy’). Thoracic and Cardiovascular Surgeon. 1990;28:291–294
  49. U.S. Census Bureau. (1995). Statistical brief: Poverty areas. Retrieved May 20, 2004; from http://www.census.gov/population/socdemo/statbriefs/povarea.html.
  50. U.S. Census Bureau. (2000). Census of population and housing 1991—Summary tape file 3: Technical documentation. Washington, DC: U.S. Department of Commerce, Economic and Statistics Administration, Bureau of the Census.
  51. U.S. Census Bureau. (2003, 10/28/2003). Summary tape file 3: Technical documentation. Retrieved 4/27/2004, 2004; from http://www.census.gov/td/stf3/append_a.html.
  52. Vlahov D, Sullivan M, Astemborski J, Nelson K. Bacterial infections and skin cleaning prior to injecting among intravenous drug users. Public Health Reports. 1992;107(5):595–598
  53. Weatherburn D, Lind B. The impact of law enforcement activity on a heroin market. Addiction. 1997;92(5):557–569
  54. Weatherburn D, Lind B. Street-level drug law enforcement and entry into methadone maintenance treatment. Addiction. 2001;96(4):577–587
  55. White M, Mehrotra A, Menendez E, Estes M, Goldenson J, Tulsky J. Jail inmates and HIV care: Provision of antiretroviral therapy and pnyeumocystis carinii pneumonia prophylaxis. International Journal of STD & AIDS. 2001;12:380–385
  56. Williams H. Drug control strategies of united states law enforcement. Bulletin on Narcotics. 1990;42(1):27–39
  57. Wilson L, Thomas D, Astemborski J, Freedman TL, Vlahov D. Prospective study of infective endocarditis among injection drug users. Journal of Infectious Diseases. 2002;185(12):1761–1766
  58. Wood E, Kerr T, Small W, Jones J, Schechter MT, Tyndall MW. The impact of a police presence on access to needle exchange programs. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2003;34(1):116–118
  59. Wood E, Spittal PM, Small W, Kerr T, Li K, Hogg RS, et al. Displacement of Canada's largest public illicit drug market in response to a police crackdown. Canadian Medical Association Journal. 2004;170(10):1551–1556
  60. Zule W. Risk and reciprocity: HIV and the injection drug user. Journal of Psychoactive Drugs. 1992;24(3):243–249

PII: S0955-3959(05)00046-0

doi: 10.1016/j.drugpo.2005.03.001

International Journal of Drug Policy
Volume 16, Issue 3 , Pages 150-160 , June 2005

Article Tools

* Image Usage & Resolution